Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,707 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06253494RecruitingPhase 1/Phase 2
Combination therapy trial for advanced endometrial cancer
This trial tests a combination of three drugs (pembrolizumab, lenvatinib, and an immune booster called N-803) plus a personalized vaccine made from your own cells, all aimed at helping your immune system fight advanced or metastatic endometrial cancer that has HER2 protein on its surface.
Bethesda, MarylandAges 18–120 - NCT06253871RecruitingPhase 1
Study of IAM1363 for HER2 Cancers
This trial tests a new oral drug called IAM1363 for people with HER2-altered cancers that have stopped responding to previous treatments. The goal is to see if the drug is safe and how well it works against these cancers.
La Jolla, CaliforniaAges 18 years+ - NCT06255223RecruitingPhase 2
Radiation therapy plus immunotherapy for advanced kidney cancer
This trial tests a combination of targeted radiation therapy with a restart of immunotherapy for people whose kidney cancer has grown after prior immunotherapy. It aims to see if radiation can help the immune system fight the cancer again.
Nanjing, JiangsuAges 18–80 - NCT06255886RecruitingPhase 4
Treatment for acid reflux in babies under 1 year
This trial tests a treatment for babies under 1 year old who have frequent and troublesome reflux (GERD). It aims to find a safe and effective way to reduce symptoms like crying, feeding problems, and breathing pauses.
Aabenraa, Region SyddanmarkAges 1 month–1 year - NCT06256354Recruiting
Managing body temperature during cancer surgery to prevent confusion
This trial tests whether carefully managing a patient's body temperature during cancer surgery can reduce the risk of postoperative delirium and improve long-term survival. It is for older adults undergoing major cancer surgery.
Chizhou, AnhuiAges 65 years+ - NCT06256575Recruiting
Diosmin for healing finger ulcers in scleroderma
This study tests whether a natural supplement called diosmin can help heal finger and toe ulcers in people with scleroderma. If you have a current ulcer that is not infected, you may be able to join.
Calgary, AlbertaAges 18 years+ - NCT06258369Recruiting
How people with hip arthritis start walking
This study looks at how people with hip arthritis begin to walk and shift their weight from one leg to the other. It aims to understand movement changes before hip replacement surgery.
LilleAges 18 years+ - NCT06258642Recruiting
Irinotecan liposome plus anlotinib for SCLC after first chemo
This trial tests a combination of two drugs—irinotecan liposome (a chemotherapy) and anlotinib (a targeted therapy)—as a second treatment for small cell lung cancer that returned quickly after initial chemo. The goal is to see if this combo can work better than standard options.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06258993Recruiting
Exercise program for breast cancer survivors
This study tests a new approach to help breast cancer survivors become more physically active. You will be asked to participate in a program that uses a smartphone app and wear a monitor to track activity.
Lebanon, New HampshireAges 18 years+ - NCT06259162Recruiting
LAG3 study in triple-negative breast cancer
This trial is studying a protein called LAG3 in triple-negative breast cancer. It is for people who will receive chemotherapy before surgery to see if LAG3 levels affect how well the treatment works.
SeoulAges Any age - NCT06260072RecruitingPhase 2
Magnesium and Riboflavin for Post-Concussion Headaches
This trial tests if taking magnesium and riboflavin (vitamin B2) can help reduce headaches after a concussion. It is for University of Virginia students who have had a concussion within the past 3 days and can swallow pills.
Charlottesville, VirginiaAges 18–40 - NCT06261918Recruiting
Breast cancer study: linking metabolism to tumor behavior
This study looks at how your metabolism (things like blood sugar and cholesterol) might be linked to tumor genes and growth in people with breast cancer. The goal is to find new ways to treat the disease based on your metabolic profile. You may be eligible if you have locally advanced breast cancer (Stage II–III) and are willing to share your medical records.
RomaAges 18 years+ - NCT06264388RecruitingPhase 2
Gene therapy plus oral drug for recurrent brain tumors
This trial tests a two-part treatment: an injected virus (DB107-RRV) plus an oral medication (DB107-FC) for people whose high-grade glioma (a type of brain tumor) has come back. The virus is designed to deliver a gene that makes the tumor sensitive to the oral drug, which then helps kill the cancer cells.
Miami, FloridaAges 18–75 - NCT06264531RecruitingPhase 2/Phase 3
Bevacizumab for adults with symptomatic, untreatable brain AVMs
This trial tests a medication called bevacizumab (given as an IV infusion) to see if it can improve symptoms in people with brain arteriovenous malformations (AVMs) that cannot be treated with standard therapies. It is for those whose AVMs cause significant disability.
Paris, Île-de-France RegionAges 18 years+ - NCT06264882RecruitingPhase 4
Study on ovarian suppression and body changes
This study looks at how temporarily stopping ovarian function affects weight, body fat, and blood vessel health in premenopausal women. If you qualify, you might help researchers understand the risks and benefits of short-term estrogen suppression.
Aurora, ColoradoAges 20–45 - NCT06265272Recruiting
PSMA-11 PET/MRI for Liver Cirrhosis
This study uses a special PET/MRI scan with a tracer called PSMA-11 to look at how liver cirrhosis affects the liver. It may help doctors better understand and monitor the disease.
Charlestown, MassachusettsAges 18–99 - NCT06266312Recruiting
Lifestyle program before breast cancer surgery
This study tests whether a program of healthy eating, exercise, and stress management before breast cancer surgery is practical and helpful for patients who will receive chemotherapy first. It aims to see if a lifestyle plan can improve your well-being during treatment.
Maastricht, LimburgAges 18 years+ - NCT06268405Recruiting
PET scan and blood test for high-risk breast screening
This study tests a new PET scan machine for the breast (positron emission mammography) along with a blood test called a liquid biopsy for women who need a biopsy after a high-risk breast screening. It may help find cancer more accurately and less invasively.
Toronto, OntarioAges 18 years+ - NCT06268444Recruiting
Infant sleep & chemical exposure in the environment
This study looks at how common chemicals in our environment (like those from plastics or pollution) may affect babies' sleep. It's for very young infants who are still drinking only milk, to help understand any links between these chemicals and sleep patterns.
AmiensAges Up to 6 months - NCT06268665RecruitingPhase 2
Tart Cherry Juice for Preventing Nerve Damage from Chemotherapy
This study tests whether tart cherry juice can help prevent nerve damage (peripheral neuropathy) caused by the chemotherapy drug paclitaxel. Participants drink tart cherry juice daily during their 12 weeks of paclitaxel treatment.
Sacramento, CaliforniaAges 18 years+ - NCT06272552Recruiting
Understanding patient feedback in kidney, cancer, and surgery care
This study aims to understand how patients' feedback and health information can be collected during routine care to improve treatment and communication. It focuses on people being treated for kidney disease, prostate cancer, breast cancer, or bariatric surgery, and will use online tools to gather your input.
Barcelona, CataloniaAges 18 years+ - NCT06272799Recruiting
T-DM1 after incomplete response to initial breast cancer therapy
This trial is for people with HER2-positive breast cancer who still had cancer after initial chemotherapy. It tests the safety and effectiveness of a drug called T-DM1 (Kadcyla) given after surgery to reduce the chance of the cancer coming back.
Rome, RomeAges Any age - NCT06272864Recruiting
A study looking at genetics of certain advanced cancers
This study tests the genes of your cancer to learn more about advanced breast, lung, melanoma, or sarcoma tumors. It may help doctors find better ways to treat these cancers in the future.
Rogers, ArkansasAges 18 years+ - NCT06273800Recruiting
Chemo timing and the menstrual cycle in breast cancer
This study tests whether the timing of chemotherapy during your menstrual cycle affects how well it works in triple-negative breast cancer. Women with regular periods who are about to start chemo before surgery may be eligible.
Amsterdam, North HollandAges 18–59
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,707 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.